Acetaminophen and Ibuprofen
ApprovedSmall molecule
Acetaminophen and Ibuprofen is one of 38 small molecule programs targeting Humerus Fracture. It is currently in Approved.
2
Indications
3
Total Trials
0
Active Trials
37
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
167 competitors in Delirium
#DrugCompanyPhaseTrials
1Ritalin
NovartisPhase 3
Victoza
Novo NordiskPhase 3
Provigil
NNuvo Research GmbH
Phase 3
IV Acetaminophen
AAFT Pharmaceuticals, Ltd.
Phase 3
Acetaminophen and Ibuprofen
UUniversity of Manitoba
Approved
Rozerem
TakedaPreclinical
Inapsine
Alnylam PharmaceuticalsPreclinical
Anerem
AAcacia Pharma Ltd
Preclinical
Spravato
WWim Janssens
Preclinical
Raldesy
PPragma
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Post Operative Pain1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Acetaminophen and Ibuprofen. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- UUniversity of Manitoba